E7777 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ONTAK®

Filter by location:

Pittsburgh, Pennsylvania1 trial

T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors

UPMC Hillman Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.